T27	Exp 105 109	that
T28	Exp 25 47	the Epstein-Barr virus
T29	Exp 212 234	the Epstein-Barr virus
T30	Exp 275 287	the survival
T31	Exp 332 350	the bcl-2 oncogene
T32	Exp 418 431	the selection
T33	Exp 558 560	it
T34	Exp 706 713	whereby
T35	Exp 682 705	the selection procedure
T36	Exp 751 774	the starting population
T37	Exp 806 835	the potentially toxic effects
T38	Exp 845 847	We
T39	Exp 927 931	that
T40	Exp 1014 1031	the viral protein
T41	Exp 1039 1050	the absence
T42	Exp 1089 1101	the NF-kappa
T43	Exp 1145 1171	the cell adhesion molecule
T44	Exp 869 879	this issue
T45	Exp 1227 1245	the first approach
T46	Exp 1309 1320	the control
T47	Exp 1560 1562	we
T48	Exp 1539 1558	the second approach
T49	Exp 1570 1584	the generality
T50	Exp 1588 1603	this phenomenon
T51	Exp 1886 1906	the same experiments
T52	Exp 2021 2023	We
T53	Exp 2043 2047	that
T54	Exp 2130 2134	that
T55	Exp 2078 2089	the panoply
T56	Exp 2135 2145	the effect
T57	Exp 2169 2177	Our data
T58	Exp 2191 2195	that
T59	Exp 2345 2362	the viral protein
R6	Coref Anaphora:T27 Antecedent:T60
R7	Coref Anaphora:T34 Antecedent:T35
R8	Coref Anaphora:T39 Antecedent:T61
R9	Coref Anaphora:T40 Antecedent:T10
R10	Coref Anaphora:T59 Antecedent:T25
T1	Protein 16 21	bcl-2
T2	Protein 72 76	LMP1
T3	Protein 259 263	LMP1
T4	Protein 336 341	bcl-2
T5	Protein 442 446	LMP1
T6	Protein 599 604	Bcl-2
T7	Protein 648 652	LMP1
T8	Protein 719 724	Bcl-2
T9	Protein 839 843	LMP1
T10	Protein 940 944	LMP1
T11	Protein 1172 1178	ICAM-1
T12	Protein 1209 1213	LMP1
T13	Protein 1293 1297	LMP1
T14	Protein 1386 1390	LMP1
T15	Protein 1450 1456	ICAM-1
T16	Protein 1529 1534	Bcl-2
T17	Protein 1630 1634	LMP1
T18	Protein 1788 1792	LMP1
T19	Protein 1865 1871	ICAM-1
T20	Protein 1876 1881	Bcl-2
T21	Protein 1968 1974	ICAM-1
T22	Protein 2014 2019	Bcl-2
T23	Protein 2048 2053	Bcl-2
T24	Protein 2121 2125	LMP1
T25	Protein 2247 2251	LMP1
T60	Exp 78 104	a B-cell-specific response
T61	Exp 889 926	two different experimental approaches
